| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Joint Instability | 14 | 2018 | 82 | 4.550 |
Why?
|
| Osteoarthritis | 17 | 2021 | 74 | 4.460 |
Why?
|
| Carpometacarpal Joints | 10 | 2021 | 13 | 4.280 |
Why?
|
| Tennis Elbow | 9 | 2023 | 12 | 4.110 |
Why?
|
| Thumb | 8 | 2021 | 22 | 3.430 |
Why?
|
| Radial Neuropathy | 4 | 2024 | 4 | 3.290 |
Why?
|
| Hand | 11 | 2024 | 142 | 3.070 |
Why?
|
| Joint Dislocations | 8 | 2023 | 27 | 2.850 |
Why?
|
| Orthopedics | 9 | 2024 | 130 | 2.670 |
Why?
|
| Fractures, Bone | 8 | 2023 | 130 | 2.580 |
Why?
|
| Relaxin | 5 | 2016 | 8 | 1.940 |
Why?
|
| Elbow Joint | 5 | 2023 | 30 | 1.860 |
Why?
|
| Radius Fractures | 6 | 2015 | 33 | 1.830 |
Why?
|
| Wrist Injuries | 5 | 2017 | 14 | 1.830 |
Why?
|
| Wounds, Gunshot | 3 | 2024 | 99 | 1.740 |
Why?
|
| Arthroplasty | 5 | 2021 | 28 | 1.620 |
Why?
|
| Adrenal Cortex Hormones | 7 | 2023 | 270 | 1.610 |
Why?
|
| Arthroscopy | 5 | 2015 | 93 | 1.600 |
Why?
|
| Nerve Compression Syndromes | 2 | 2023 | 19 | 1.590 |
Why?
|
| De Quervain Disease | 3 | 2021 | 7 | 1.530 |
Why?
|
| Trapezium Bone | 5 | 2021 | 7 | 1.460 |
Why?
|
| Humans | 111 | 2024 | 89567 | 1.460 |
Why?
|
| Olecranon Process | 2 | 2021 | 3 | 1.460 |
Why?
|
| Orthopedic Procedures | 7 | 2024 | 129 | 1.390 |
Why?
|
| Wrist Joint | 8 | 2022 | 24 | 1.380 |
Why?
|
| Tendon Transfer | 2 | 2021 | 6 | 1.320 |
Why?
|
| Military Personnel | 4 | 2010 | 92 | 1.210 |
Why?
|
| Musculoskeletal Diseases | 5 | 2015 | 34 | 1.150 |
Why?
|
| Arm Injuries | 4 | 2017 | 10 | 1.130 |
Why?
|
| Elbow | 3 | 2023 | 12 | 1.110 |
Why?
|
| Cartilage, Articular | 4 | 2016 | 69 | 1.080 |
Why?
|
| Workload | 3 | 2020 | 129 | 1.030 |
Why?
|
| Tenosynovitis | 2 | 2021 | 7 | 1.030 |
Why?
|
| Scaphoid Bone | 3 | 2010 | 6 | 1.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2024 | 115 | 1.010 |
Why?
|
| Trigger Finger Disorder | 2 | 2023 | 5 | 1.000 |
Why?
|
| Arthroplasty, Replacement, Finger | 2 | 2018 | 2 | 1.000 |
Why?
|
| Humeral Fractures | 2 | 2024 | 18 | 1.000 |
Why?
|
| Male | 49 | 2024 | 42464 | 0.990 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2020 | 17 | 0.970 |
Why?
|
| Bursitis | 2 | 2021 | 12 | 0.960 |
Why?
|
| Female | 47 | 2024 | 46371 | 0.940 |
Why?
|
| Contracture | 3 | 2022 | 18 | 0.930 |
Why?
|
| Fingers | 2 | 2020 | 69 | 0.920 |
Why?
|
| Fracture Fixation, Internal | 4 | 2020 | 69 | 0.920 |
Why?
|
| Adult | 34 | 2024 | 26684 | 0.900 |
Why?
|
| Arthrodesis | 3 | 2021 | 26 | 0.890 |
Why?
|
| Physical Therapy Modalities | 5 | 2022 | 83 | 0.880 |
Why?
|
| Range of Motion, Articular | 5 | 2023 | 155 | 0.870 |
Why?
|
| Osteogenesis | 7 | 2019 | 258 | 0.860 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2024 | 113 | 0.850 |
Why?
|
| Middle Aged | 30 | 2024 | 25996 | 0.830 |
Why?
|
| Hand Joints | 2 | 2015 | 3 | 0.820 |
Why?
|
| Ganglion Cysts | 1 | 2022 | 4 | 0.810 |
Why?
|
| Internship and Residency | 4 | 2014 | 1060 | 0.800 |
Why?
|
| Wrist | 1 | 2022 | 26 | 0.800 |
Why?
|
| Young Adult | 17 | 2024 | 6362 | 0.780 |
Why?
|
| Sex Factors | 11 | 2016 | 1073 | 0.760 |
Why?
|
| Emergency Medicine | 2 | 2014 | 125 | 0.760 |
Why?
|
| Median Neuropathy | 1 | 2020 | 1 | 0.730 |
Why?
|
| Tendon Injuries | 3 | 2016 | 36 | 0.730 |
Why?
|
| Aged | 22 | 2024 | 19144 | 0.710 |
Why?
|
| Open Fracture Reduction | 1 | 2020 | 4 | 0.700 |
Why?
|
| Ulna Fractures | 1 | 2020 | 6 | 0.700 |
Why?
|
| Glucocorticoids | 4 | 2023 | 357 | 0.700 |
Why?
|
| Military Medicine | 2 | 2010 | 21 | 0.700 |
Why?
|
| Societies, Medical | 1 | 2024 | 581 | 0.700 |
Why?
|
| Growth Differentiation Factor 2 | 6 | 2019 | 154 | 0.670 |
Why?
|
| Occupational Diseases | 1 | 2020 | 55 | 0.660 |
Why?
|
| Finger Joint | 2 | 2018 | 14 | 0.660 |
Why?
|
| Finger Injuries | 2 | 2018 | 12 | 0.660 |
Why?
|
| Trapezoid Bone | 2 | 2009 | 2 | 0.660 |
Why?
|
| Athletic Injuries | 4 | 2016 | 97 | 0.650 |
Why?
|
| Risk Factors | 13 | 2024 | 5523 | 0.640 |
Why?
|
| Radiography | 10 | 2014 | 806 | 0.640 |
Why?
|
| Prospective Studies | 12 | 2023 | 4309 | 0.640 |
Why?
|
| Radius | 2 | 2017 | 31 | 0.630 |
Why?
|
| Educational Measurement | 2 | 2011 | 231 | 0.620 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 434 | 0.610 |
Why?
|
| Ischemia | 1 | 2020 | 252 | 0.610 |
Why?
|
| Sick Leave | 1 | 2018 | 13 | 0.610 |
Why?
|
| Bone and Bones | 2 | 2019 | 271 | 0.600 |
Why?
|
| Bone Density | 2 | 2018 | 208 | 0.590 |
Why?
|
| Ligaments | 2 | 2014 | 33 | 0.580 |
Why?
|
| Receptors, Peptide | 2 | 2014 | 25 | 0.580 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 168 | 0.570 |
Why?
|
| Fracture Fixation | 2 | 2015 | 31 | 0.570 |
Why?
|
| United States | 16 | 2024 | 7041 | 0.570 |
Why?
|
| Gymnastics | 1 | 2017 | 3 | 0.570 |
Why?
|
| Skin Neoplasms | 2 | 2014 | 588 | 0.570 |
Why?
|
| Osteoporosis | 1 | 2018 | 121 | 0.570 |
Why?
|
| Osteoporotic Fractures | 2 | 2015 | 47 | 0.570 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2017 | 18 | 0.560 |
Why?
|
| Collagen Type II | 1 | 2016 | 14 | 0.560 |
Why?
|
| Arthritis | 2 | 2014 | 48 | 0.560 |
Why?
|
| Tendons | 2 | 2007 | 44 | 0.550 |
Why?
|
| Bone Remodeling | 2 | 2015 | 23 | 0.540 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2014 | 131 | 0.540 |
Why?
|
| Shoulder Injuries | 1 | 2016 | 17 | 0.530 |
Why?
|
| Ligaments, Articular | 3 | 2013 | 38 | 0.530 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2016 | 170 | 0.530 |
Why?
|
| Injections | 3 | 2021 | 116 | 0.530 |
Why?
|
| Hand Injuries | 2 | 2013 | 16 | 0.530 |
Why?
|
| Tendinopathy | 3 | 2019 | 5 | 0.510 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2014 | 1097 | 0.500 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 3658 | 0.500 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2013 | 16 | 0.490 |
Why?
|
| Rotator Cuff | 1 | 2015 | 41 | 0.490 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2015 | 33 | 0.490 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 305 | 0.490 |
Why?
|
| Incidence | 7 | 2021 | 1598 | 0.480 |
Why?
|
| Peer Review, Research | 1 | 2014 | 36 | 0.470 |
Why?
|
| Veterans | 1 | 2015 | 85 | 0.470 |
Why?
|
| Shoulder Dislocation | 2 | 2011 | 17 | 0.470 |
Why?
|
| Synovial Membrane | 1 | 2014 | 28 | 0.470 |
Why?
|
| Treatment Outcome | 11 | 2022 | 8209 | 0.470 |
Why?
|
| Injections, Intra-Articular | 4 | 2018 | 27 | 0.470 |
Why?
|
| Radial Nerve | 2 | 2024 | 3 | 0.460 |
Why?
|
| Aged, 80 and over | 12 | 2024 | 6766 | 0.460 |
Why?
|
| Surveys and Questionnaires | 7 | 2016 | 2641 | 0.460 |
Why?
|
| Immunocompromised Host | 2 | 2014 | 142 | 0.450 |
Why?
|
| Retrospective Studies | 11 | 2024 | 9112 | 0.440 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 1131 | 0.440 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2013 | 9 | 0.430 |
Why?
|
| Vitamin D | 1 | 2015 | 269 | 0.430 |
Why?
|
| Platelet-Rich Plasma | 1 | 2013 | 11 | 0.430 |
Why?
|
| Age Factors | 7 | 2015 | 1877 | 0.430 |
Why?
|
| Adolescent | 10 | 2024 | 9299 | 0.420 |
Why?
|
| Rheumatic Diseases | 1 | 2013 | 26 | 0.420 |
Why?
|
| Disability Evaluation | 3 | 2021 | 139 | 0.420 |
Why?
|
| Sports | 1 | 2013 | 40 | 0.410 |
Why?
|
| Postoperative Complications | 5 | 2024 | 2296 | 0.400 |
Why?
|
| Pain Measurement | 3 | 2021 | 331 | 0.390 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2016 | 95 | 0.390 |
Why?
|
| Cohort Studies | 6 | 2018 | 2878 | 0.390 |
Why?
|
| Biomarkers | 5 | 2016 | 1768 | 0.390 |
Why?
|
| Musculoskeletal System | 1 | 2011 | 15 | 0.380 |
Why?
|
| Biocompatible Materials | 2 | 2019 | 198 | 0.380 |
Why?
|
| Fellowships and Scholarships | 2 | 2014 | 124 | 0.380 |
Why?
|
| Sodium Chloride | 1 | 2011 | 88 | 0.380 |
Why?
|
| Carbon | 1 | 2011 | 90 | 0.370 |
Why?
|
| Certification | 1 | 2011 | 61 | 0.370 |
Why?
|
| Surgical Wound Infection | 2 | 2024 | 201 | 0.370 |
Why?
|
| Primary Health Care | 1 | 2014 | 352 | 0.360 |
Why?
|
| Blast Injuries | 1 | 2010 | 12 | 0.360 |
Why?
|
| Viscosupplements | 1 | 2010 | 5 | 0.360 |
Why?
|
| Sports Medicine | 1 | 2011 | 58 | 0.360 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 373 | 0.350 |
Why?
|
| Intra-Articular Fractures | 1 | 2010 | 5 | 0.350 |
Why?
|
| Organ Transplantation | 1 | 2014 | 280 | 0.350 |
Why?
|
| Databases, Factual | 4 | 2021 | 860 | 0.350 |
Why?
|
| Foreign Bodies | 1 | 2010 | 66 | 0.340 |
Why?
|
| Growth Differentiation Factors | 3 | 2019 | 57 | 0.340 |
Why?
|
| Isometric Contraction | 1 | 2009 | 42 | 0.340 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1862 | 0.330 |
Why?
|
| Ankle Injuries | 2 | 2011 | 29 | 0.330 |
Why?
|
| Sweden | 2 | 2020 | 40 | 0.330 |
Why?
|
| Professional Competence | 1 | 2009 | 69 | 0.320 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 1723 | 0.320 |
Why?
|
| Carpal Joints | 1 | 2008 | 1 | 0.320 |
Why?
|
| Logistic Models | 3 | 2020 | 1214 | 0.310 |
Why?
|
| Receptors, Notch | 2 | 2019 | 126 | 0.310 |
Why?
|
| Upper Extremity | 3 | 2021 | 53 | 0.310 |
Why?
|
| Interinstitutional Relations | 1 | 2008 | 29 | 0.310 |
Why?
|
| Cell Differentiation | 6 | 2019 | 1529 | 0.310 |
Why?
|
| Carpal Bones | 2 | 2012 | 12 | 0.300 |
Why?
|
| Fractures, Closed | 1 | 2007 | 9 | 0.290 |
Why?
|
| Blood Glucose | 2 | 2024 | 837 | 0.290 |
Why?
|
| Internal Medicine | 1 | 2011 | 362 | 0.290 |
Why?
|
| Rupture | 3 | 2016 | 61 | 0.290 |
Why?
|
| Disease Progression | 4 | 2020 | 1463 | 0.280 |
Why?
|
| Myositis Ossificans | 1 | 2006 | 3 | 0.280 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 2015 | 0.270 |
Why?
|
| Bone Screws | 2 | 2020 | 45 | 0.270 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 99 | 0.270 |
Why?
|
| Bone Transplantation | 2 | 2010 | 67 | 0.270 |
Why?
|
| Registries | 3 | 2021 | 791 | 0.270 |
Why?
|
| Rare Diseases | 1 | 2006 | 69 | 0.260 |
Why?
|
| Cholagogues and Choleretics | 1 | 2005 | 10 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 538 | 0.260 |
Why?
|
| Research Design | 2 | 2019 | 586 | 0.260 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2005 | 25 | 0.260 |
Why?
|
| Splints | 3 | 2013 | 10 | 0.260 |
Why?
|
| Fluoroscopy | 2 | 2012 | 123 | 0.260 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2005 | 51 | 0.250 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 469 | 0.250 |
Why?
|
| Risk Assessment | 4 | 2024 | 2304 | 0.250 |
Why?
|
| Attitude to Computers | 1 | 2004 | 12 | 0.240 |
Why?
|
| Electronic Mail | 1 | 2004 | 15 | 0.240 |
Why?
|
| Foot Injuries | 1 | 2004 | 10 | 0.230 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2014 | 17 | 0.230 |
Why?
|
| Fractures, Multiple | 1 | 2023 | 3 | 0.230 |
Why?
|
| Preoperative Period | 1 | 2024 | 94 | 0.230 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 854 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2011 | 606 | 0.220 |
Why?
|
| Exsanguination | 1 | 2023 | 3 | 0.220 |
Why?
|
| Early Ambulation | 1 | 2023 | 25 | 0.220 |
Why?
|
| Joint Capsule Release | 2 | 2013 | 2 | 0.220 |
Why?
|
| Forearm | 1 | 2023 | 31 | 0.220 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 984 | 0.220 |
Why?
|
| Peripheral Nerves | 1 | 2023 | 37 | 0.220 |
Why?
|
| Hyperglycemia | 1 | 2024 | 172 | 0.210 |
Why?
|
| Child | 5 | 2022 | 7214 | 0.210 |
Why?
|
| Ambulatory Care | 1 | 2024 | 186 | 0.210 |
Why?
|
| Observer Variation | 3 | 2015 | 613 | 0.210 |
Why?
|
| Analysis of Variance | 3 | 2018 | 899 | 0.210 |
Why?
|
| Sickness Impact Profile | 1 | 2002 | 26 | 0.210 |
Why?
|
| Biomechanical Phenomena | 3 | 2014 | 478 | 0.200 |
Why?
|
| Self-Assessment | 1 | 2002 | 47 | 0.200 |
Why?
|
| Prevalence | 2 | 2024 | 1247 | 0.200 |
Why?
|
| Internet | 1 | 2004 | 321 | 0.200 |
Why?
|
| Hand Strength | 2 | 2020 | 52 | 0.190 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 166 | 0.190 |
Why?
|
| Physicians | 1 | 2009 | 691 | 0.190 |
Why?
|
| Bursa, Synovial | 1 | 2021 | 3 | 0.190 |
Why?
|
| Lunate Bone | 1 | 2001 | 2 | 0.190 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2021 | 14 | 0.190 |
Why?
|
| Shoulder Joint | 1 | 2002 | 91 | 0.190 |
Why?
|
| Recovery of Function | 2 | 2013 | 293 | 0.190 |
Why?
|
| Fascia | 1 | 2001 | 31 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 252 | 0.190 |
Why?
|
| Violence | 1 | 2023 | 153 | 0.190 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 364 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2021 | 30 | 0.180 |
Why?
|
| Median Nerve | 1 | 2020 | 12 | 0.180 |
Why?
|
| Postoperative Care | 2 | 2018 | 232 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 327 | 0.180 |
Why?
|
| Sampling Studies | 1 | 2020 | 72 | 0.180 |
Why?
|
| Bone Plates | 1 | 2020 | 23 | 0.170 |
Why?
|
| Quality of Health Care | 1 | 2023 | 386 | 0.170 |
Why?
|
| Open Access Publishing | 1 | 2019 | 1 | 0.170 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 191 | 0.170 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2020 | 61 | 0.170 |
Why?
|
| Scientific Misconduct | 1 | 2019 | 10 | 0.170 |
Why?
|
| Peer Review | 1 | 2019 | 23 | 0.170 |
Why?
|
| Fatal Outcome | 1 | 2020 | 296 | 0.170 |
Why?
|
| Surgeons | 1 | 2023 | 249 | 0.170 |
Why?
|
| Age Distribution | 2 | 2010 | 199 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2019 | 3395 | 0.160 |
Why?
|
| Ethics, Research | 1 | 2019 | 52 | 0.160 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 66 | 0.160 |
Why?
|
| Transfection | 2 | 2019 | 909 | 0.160 |
Why?
|
| Bioprinting | 1 | 2019 | 13 | 0.160 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2018 | 2 | 0.160 |
Why?
|
| Hajdu-Cheney Syndrome | 1 | 2018 | 1 | 0.160 |
Why?
|
| Athletes | 2 | 2016 | 52 | 0.160 |
Why?
|
| Receptor, Notch2 | 1 | 2018 | 6 | 0.160 |
Why?
|
| Colitis, Ulcerative | 1 | 2005 | 749 | 0.160 |
Why?
|
| Umbilical Cord | 1 | 2018 | 40 | 0.160 |
Why?
|
| Publishing | 1 | 2019 | 90 | 0.160 |
Why?
|
| Manipulation, Orthopedic | 1 | 2018 | 5 | 0.160 |
Why?
|
| Stress, Mechanical | 2 | 2011 | 253 | 0.160 |
Why?
|
| Adipogenesis | 1 | 2018 | 39 | 0.160 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 120 | 0.150 |
Why?
|
| Hydrogels | 1 | 2019 | 87 | 0.150 |
Why?
|
| Physician's Role | 1 | 2020 | 176 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2019 | 221 | 0.150 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 115 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 979 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2018 | 65 | 0.150 |
Why?
|
| Critical Illness | 1 | 2020 | 307 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1850 | 0.140 |
Why?
|
| Knee Joint | 1 | 2018 | 165 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2020 | 323 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2019 | 189 | 0.140 |
Why?
|
| Cranial Sutures | 1 | 2017 | 47 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 262 | 0.140 |
Why?
|
| Weight-Bearing | 1 | 2017 | 67 | 0.140 |
Why?
|
| Retroviridae | 1 | 2017 | 79 | 0.140 |
Why?
|
| Critical Care | 1 | 2020 | 383 | 0.140 |
Why?
|
| Women, Working | 1 | 2016 | 7 | 0.140 |
Why?
|
| Founder Effect | 1 | 2017 | 104 | 0.140 |
Why?
|
| Orthopedic Surgeons | 1 | 2016 | 14 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2020 | 397 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 2666 | 0.140 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 94 | 0.140 |
Why?
|
| Craniosynostoses | 1 | 2017 | 77 | 0.130 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 743 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1705 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 143 | 0.130 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2016 | 50 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2011 | 590 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 794 | 0.130 |
Why?
|
| Osteocalcin | 1 | 2015 | 26 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2018 | 711 | 0.130 |
Why?
|
| Physicians, Women | 1 | 2016 | 57 | 0.130 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 132 | 0.130 |
Why?
|
| Collagen Type I | 1 | 2015 | 72 | 0.130 |
Why?
|
| Auditory Threshold | 1 | 2015 | 15 | 0.120 |
Why?
|
| Career Choice | 1 | 2016 | 148 | 0.120 |
Why?
|
| Cochlear Implantation | 1 | 2015 | 34 | 0.120 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 22 | 0.120 |
Why?
|
| Rotator Cuff Injuries | 1 | 2015 | 43 | 0.120 |
Why?
|
| Hearing | 1 | 2015 | 57 | 0.120 |
Why?
|
| Parathyroid Hormone | 1 | 2015 | 220 | 0.120 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2014 | 7 | 0.120 |
Why?
|
| Femoral Fractures | 1 | 2014 | 27 | 0.120 |
Why?
|
| Fracture Healing | 1 | 2014 | 36 | 0.120 |
Why?
|
| Wound Healing | 2 | 2011 | 360 | 0.120 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 10 | 0.120 |
Why?
|
| Hearing Loss | 1 | 2015 | 62 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 1727 | 0.120 |
Why?
|
| Femur | 1 | 2015 | 112 | 0.120 |
Why?
|
| Colorado | 1 | 2014 | 37 | 0.120 |
Why?
|
| Scapula | 1 | 2014 | 24 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 775 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 152 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2014 | 130 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 421 | 0.110 |
Why?
|
| Methylprednisolone | 1 | 2013 | 64 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 158 | 0.110 |
Why?
|
| Pain | 2 | 2019 | 399 | 0.110 |
Why?
|
| Arthroscopes | 1 | 2012 | 1 | 0.110 |
Why?
|
| Joint Capsule | 1 | 2012 | 6 | 0.110 |
Why?
|
| Ganglia | 1 | 2012 | 14 | 0.110 |
Why?
|
| Remission, Spontaneous | 1 | 2012 | 52 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2014 | 234 | 0.100 |
Why?
|
| Reoperation | 1 | 2015 | 603 | 0.100 |
Why?
|
| HEK293 Cells | 3 | 2019 | 646 | 0.100 |
Why?
|
| Palmar Plate | 1 | 2012 | 1 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 384 | 0.100 |
Why?
|
| Canada | 2 | 2014 | 208 | 0.100 |
Why?
|
| Peptides | 1 | 2015 | 649 | 0.100 |
Why?
|
| Humerus | 2 | 2009 | 31 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2018 | 725 | 0.100 |
Why?
|
| Mutation | 2 | 2018 | 4159 | 0.100 |
Why?
|
| Arthrometry, Articular | 1 | 2011 | 3 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 661 | 0.100 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2011 | 8 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2015 | 353 | 0.100 |
Why?
|
| Marfan Syndrome | 1 | 2011 | 28 | 0.100 |
Why?
|
| Equipment Design | 1 | 2012 | 420 | 0.090 |
Why?
|
| Baseball | 1 | 2011 | 18 | 0.090 |
Why?
|
| Monteggia's Fracture | 1 | 2011 | 1 | 0.090 |
Why?
|
| Shoulder | 1 | 2011 | 42 | 0.090 |
Why?
|
| Knee Injuries | 1 | 2011 | 54 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2011 | 40 | 0.090 |
Why?
|
| Specialties, Surgical | 1 | 2011 | 66 | 0.090 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 652 | 0.090 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 231 | 0.090 |
Why?
|
| Metacarpal Bones | 1 | 2010 | 12 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2010 | 50 | 0.090 |
Why?
|
| Metals | 1 | 2010 | 93 | 0.090 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 51 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2010 | 221 | 0.090 |
Why?
|
| Limb Salvage | 1 | 2010 | 35 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2011 | 312 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 624 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1605 | 0.080 |
Why?
|
| Skin Transplantation | 1 | 2011 | 184 | 0.080 |
Why?
|
| Forearm Injuries | 1 | 2009 | 4 | 0.080 |
Why?
|
| Syndrome | 1 | 2010 | 449 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2021 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 60 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2010 | 234 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2009 | 94 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 29 | 0.080 |
Why?
|
| Thigh | 1 | 2008 | 39 | 0.080 |
Why?
|
| Quality of Life | 2 | 2019 | 1671 | 0.080 |
Why?
|
| Risk | 1 | 2010 | 655 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2008 | 171 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 1 | 2009 | 85 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2019 | 1668 | 0.070 |
Why?
|
| Travel | 1 | 2008 | 71 | 0.070 |
Why?
|
| Living Donors | 1 | 2011 | 339 | 0.070 |
Why?
|
| Fractures, Comminuted | 1 | 2007 | 6 | 0.070 |
Why?
|
| Immobilization | 1 | 2007 | 21 | 0.070 |
Why?
|
| Arthralgia | 1 | 2007 | 39 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2015 | 3754 | 0.070 |
Why?
|
| Glucose | 1 | 2010 | 629 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 401 | 0.070 |
Why?
|
| Collagen | 1 | 2009 | 294 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 414 | 0.070 |
Why?
|
| Mice | 5 | 2019 | 11828 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1798 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2006 | 57 | 0.070 |
Why?
|
| Mucopolysaccharidoses | 1 | 2006 | 1 | 0.070 |
Why?
|
| Muscular Diseases | 1 | 2006 | 64 | 0.070 |
Why?
|
| Intraoperative Period | 2 | 2012 | 91 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2884 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2011 | 791 | 0.060 |
Why?
|
| Recurrence | 1 | 2008 | 1143 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2003 | 0.060 |
Why?
|
| Age of Onset | 1 | 2005 | 314 | 0.060 |
Why?
|
| Rectum | 1 | 2005 | 148 | 0.060 |
Why?
|
| Animals | 7 | 2019 | 27476 | 0.060 |
Why?
|
| Amyloidosis | 1 | 2006 | 130 | 0.060 |
Why?
|
| Health Facilities | 1 | 2023 | 37 | 0.060 |
Why?
|
| Attitude | 1 | 2004 | 130 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2494 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 476 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2023 | 88 | 0.050 |
Why?
|
| Documentation | 1 | 2023 | 103 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 152 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1576 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 79 | 0.050 |
Why?
|
| Colon | 1 | 2005 | 519 | 0.050 |
Why?
|
| Chondrosarcoma | 1 | 2002 | 50 | 0.050 |
Why?
|
| Thymidine | 1 | 2001 | 59 | 0.050 |
Why?
|
| Gene Expression | 2 | 2017 | 1309 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2001 | 64 | 0.050 |
Why?
|
| Anxiety | 1 | 2023 | 310 | 0.050 |
Why?
|
| Gadolinium | 1 | 2001 | 103 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 27 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2021 | 146 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2020 | 76 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 461 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2002 | 334 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2001 | 345 | 0.040 |
Why?
|
| Depression | 1 | 2023 | 510 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 100 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 17 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3465 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 362 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2019 | 62 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 281 | 0.040 |
Why?
|
| Transposon Resolvases | 1 | 2018 | 7 | 0.040 |
Why?
|
| Triamcinolone | 1 | 2018 | 18 | 0.040 |
Why?
|
| Chondrogenesis | 1 | 2018 | 28 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 282 | 0.040 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2018 | 47 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 77 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 205 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 56 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 538 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2005 | 1172 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1928 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 253 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 996 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 503 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 426 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 2763 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 194 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2019 | 164 | 0.040 |
Why?
|
| Simian virus 40 | 1 | 2017 | 35 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 2017 | 41 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2017 | 75 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 154 | 0.040 |
Why?
|
| Virion | 1 | 2017 | 59 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2017 | 97 | 0.030 |
Why?
|
| Work-Life Balance | 1 | 2016 | 6 | 0.030 |
Why?
|
| Job Description | 1 | 2016 | 9 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2018 | 446 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 274 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 816 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 309 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2016 | 79 | 0.030 |
Why?
|
| Adipocytes | 1 | 2017 | 163 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 351 | 0.030 |
Why?
|
| Mentors | 1 | 2016 | 88 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 179 | 0.030 |
Why?
|
| Hearing Tests | 1 | 2015 | 11 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2015 | 25 | 0.030 |
Why?
|
| Cochlear Implants | 1 | 2015 | 36 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 774 | 0.030 |
Why?
|
| Apoptosis | 1 | 2001 | 1717 | 0.030 |
Why?
|
| Bony Callus | 1 | 2014 | 5 | 0.030 |
Why?
|
| Wnt-5a Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
| South Africa | 1 | 2014 | 60 | 0.030 |
Why?
|
| Cartilage | 1 | 2014 | 116 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 65 | 0.030 |
Why?
|
| United Kingdom | 1 | 2014 | 164 | 0.030 |
Why?
|
| Osteophyte | 1 | 2013 | 2 | 0.030 |
Why?
|
| International Cooperation | 1 | 2014 | 125 | 0.030 |
Why?
|
| Ulnar Nerve | 1 | 2013 | 7 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 70 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 1148 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2013 | 88 | 0.030 |
Why?
|
| Pronation | 1 | 2012 | 6 | 0.030 |
Why?
|
| Supination | 1 | 2012 | 6 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 2487 | 0.030 |
Why?
|
| Cadaver | 1 | 2012 | 186 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 305 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 3237 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2582 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1982 | 0.020 |
Why?
|
| Infant | 1 | 2017 | 3174 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 599 | 0.020 |
Why?
|
| Time Factors | 1 | 1999 | 5333 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2384 | 0.020 |
Why?
|
| Ulna | 1 | 2006 | 15 | 0.020 |
Why?
|
| K562 Cells | 1 | 2002 | 44 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 258 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 133 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 378 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2001 | 123 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2002 | 212 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1048 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2002 | 475 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 692 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2002 | 604 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2063 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 2329 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3024 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2002 | 1281 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 1445 | 0.010 |
Why?
|